CIK 0002130606
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Obsidian Therapeutics, Inc.
Sign in to watch- Ticker
- OBX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 421977778
- Phone
- +1 781-806-6245
- Business address
- 1030 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Gazelle Parent, Inc.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 1 of 1 · 6 filings